Bio-Techne vs Revvity vs Agilent Technologies and 1 More Revenue Comparison
Compare financial metrics side-by-side using real SEC EDGAR data
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Bio-Techne 0.321, Revvity 0.73, Agilent Technologies 1.878, Charles River Laboratories 1.004.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Bio-Techne, Revvity, Agilent Technologies, Charles River Laboratories.| Metric | Bio-Techne | Revvity | Agilent Technologies | Charles River Laboratories |
|---|---|---|---|---|
| Market Cap | $11.36B | $17.20B | $48.09B | $14.54B |
| Revenue | $321.00M | $730.00M | $1.88B | $1.00B |
| Cost of Revenue | $110.00M | $313.00M | $836.00M | $641.00M |
| Gross Profit | $211.00M | $417.00M | $1.04B | $363.00M |
| Operating Income | $74.00M | $89.00M | $444.00M | $120.00M |
| Net Income | $55.00M | $52.00M | $362.00M | $-1.00M |
| R&D Expense | $24.00M | $49.00M | $123.00M | $0 |
| Earnings Per Share | $0.36 | $0.47 | $1.28 | -$0.03 |
| Gross Margin | 65.8% | 57.1% | 55.5% | 36.2% |
| Operating Margin | 23.1% | 12.2% | 23.6% | 11.9% |
| Net Profit Margin | 17.0% | 7.1% | 19.3% | -0.1% |
| Free Cash Flow | $87.00M | $181.00M | $439.00M | $149.00M |
| Cumulative Free Cash Flow | $3.60B | $7.25B | $18.76B | $5.67B |
| Operating Cash Flow | $95.00M | $192.00M | $519.00M | $180.00M |
| Cash & Equivalents | $265.00M | $1.02B | $1.76B | $192.00M |